Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients
Status:
Terminated
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
To evaluate whether the combined therapy of two nucleosides plus one nucleotide (Trizivir +
TDF) manages to keep CD4 lymphocytes stable in patients with HIV infection on antiretroviral
treatment that present virological failure and multiple resistance to antiretrovirals.
Phase:
Phase 4
Details
Lead Sponsor:
Germans Trias i Pujol Hospital
Collaborators:
Fundacio Lluita Contra la SIDA Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia